Abstract
OP09 Anti TNF-α therapy is a major cost driver in inflammatory bowel disease: Results from the COIN study
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have